European Economic
and Social Committee
Innovation and health package
See EESC opinion in all languages under Related documents at the end of this page.
The EESC reflects in the opinion its view on a package of three Commission proposals: COM(2012) 542 final - 2012/0266 (COD), COM(2012) 541 final – 2012/0267 (COD) and COM(2012) 540 final (INT/665 - 666 and 667).
Key points:
- The EESC welcomes the recast of the current regulatory system by the Commission that goes beyond a mere simplification of the framework and puts in place more effective rules, strengthening the pre‑market approval procedures and in particular the post-market surveillance.
- The EESC strongly supports the legal form of a "Regulation" instead of a "Directive" so as to reduce the room for diverging interpretation by individual Member States, providing more equality for European patients and a level playing field for suppliers.
- Beside safety, fast access to the latest medical technologies also represents an important benefit for patients. Considerable delays in accessing the new devices would harm patients by reducing their treatment choices (possibly life-supporting) or at least prevent them from reducing their disabilities and improving their quality of life.
- The EESC generally supports high standard approval procedures for high-risk MDs and IVDs before entering the market, in which safety and efficacy must be proven by the results of adequate clinical tests and investigations.
- The EESC welcomes the introduction of a Unique Device Identification (UDI) to be assigned to each device, allowing faster identification and better traceability. The EESC would also welcome a fully workable central registration tool (Eudamed) which would eliminate multiple registrations and considerably decrease the costs for SMEs.
Other relevant EESC opinions on:
- Medical devices / in vitro diagnostic (CESE 1153/1995 - ENVI/407)
- Medical devices incorporating stable derivatives of human blood or human plasma (CESE 1484/2001 - SOC/088)
- Active implantable medical devices (CESE 339/1993 - IND/484)
- Medical devices (CESE 86/1992 - IND/435)
For more information please contact the INT Section Secretariat
Downloads
-
Presentation by the EC, 26.09.2012
Recommended for you
Il-KESE jappella għal regolamentazzjoni b’saħħitha u ssemplifikata tal-kriptoassi
News
Il-Kumitat Ekonomiku u Soċjali Ewropew jappoġġja żieda fir-regolamentazzjoni tal-kriptoassi, b’regoli robusti u koerenti biex l-investituri fl-UE jiġu protetti aħjar, f’konformità mal-miżuri attwali…
L-istrumentalizzazzjoni tal-migranti u l-kriżi tar-refuġjati tal-Ukrajna jappellaw għal bidu ġdid għall-politika dwar il-migrazzjoni
News
L-istrumentalizzazzjoni tal-migranti sostnuta mill-Istat, li għandha l-għan li tiddestabbilizza lill-UE, u l-gwerra attwali fl-Ukrajna, li wasslet għal influss bla preċedent ta’ refuġjati, jagħmluha…
“L-Ewropa Tiegħek, Leħnek” 2023: Iż-żgħażagħ jitolbu UE aktar trasparenti, diġitali u semplifikata
News
Fit-23 u l-24 ta’ Marzu, il-Kumitat Ekonomiku u Soċjali Ewropew (KESE) ospita l-14-il avveniment L-Ewropa Tiegħek, Leħnek!, li laqqa’ fi Brussell 105 studenti minn 35 skola mis-27 Stat Membru tal-UE…
Euro-Med – L-organizzazzjonijiet tas-soċjetà ċivili huma essenzjali biex l-ekonomija u s-soċjetà jaħdmu tajjeb
News
Matul is-sessjoni plenarja ta’ Diċembru tal-Kumitat Ekonomiku u Soċjali Ewropew (KESE) sar dibattitu dwar ir-rikostruzzjoni u r-reżiljenza tar-reġjun Ewro‑Mediterranju wara l-pandemija tal-COVID-19.…
Il-KESE jiftaħ l-applikazzjonijiet għall-Premju tiegħu għas-Soċjetà Ċivili li se jkun qed jindirizza s-saħħa mentali
News
L-organizzazzjonijiet tas-soċjetà ċivili, l-individwi u l-kumpaniji privati issa jistgħu jdaħħlu l-proġetti tagħhom mingħajr skop ta’ qligħ għall-premju tal-KESE ddedikat għall-appoġġ tal-benesseri…